SCHEMBL20054547

SCHEMBL20054547

CC(=O)c1ccc2cc3cc(-c4cnc(CN)[nH]4)ccc3cc2c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 1/20 0.38
CYP3A4 P08684 2/20 0.37
CYP17A1 P05093 1/20 0.37
NQO2 P16083 1/20 0.36
SCN10A Q9Y5Y9 3/20 0.36
CYP1A2 P05177 1/20 0.36
CYP11B1 P15538 1/20 0.36
CYP11B2 P19099 1/20 0.36
MKNK2 Q9HBH9 3/20 0.35
MAP4K4 O95819 2/20 0.35
CSNK1G2 P78368 2/20 0.35
CLK4 Q9HAZ1 2/20 0.35
MAP4K5 Q9Y4K4 2/20 0.35
SYK P43405 2/20 0.35
PLK4 O00444 1/20 0.35
DCLK1 O15075 1/20 0.35
ROCK2 O75116 1/20 0.35
PRKD3 O94806 1/20 0.35
PAK4 O96013 1/20 0.35
CHEK2 O96017 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20054471 0.85 NLN (0.42) SCN10ACYP11B1CYP11B2NLNPYGL
SCHEMBL20054552 0.81 NLN (0.43) SCN10ACYP11B1CYP11B2NLNPYGL
SCHEMBL19388433 0.79 NLN (0.39) CYP2A6CYP3A4CYP17A1NQO2CYP1A2
SCHEMBL15116782 0.79 NLN (0.39) CYP2A6CYP3A4CYP17A1NQO2CYP1A2
SCHEMBL12648128 0.79 NLN (0.41) SCN10ANLN
SCHEMBL20054396 0.74 GSK3B (0.55) HDAC1HDAC6GSK3BDYRK1A
SCHEMBL20054519 0.72 CACNA1B (0.41) SCN10AROCK2HDAC1MAPTGSK3B
SCHEMBL20054430 0.71 AAK1 (0.41) NLNMAPT
SCHEMBL20054398 0.71 SSTR3 (0.42) CYP3A4CYP17A1HDAC1HDAC6GSK3B
SCHEMBL15116812 0.71 SSTR3 (0.42) CYP3A4CYP17A1HDAC1HDAC6GSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3019196-B1 COMBINATIONS OF HEPATITIS C VIRUS INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2018-06-06 EP disclosed
EP-2802326-B1 HEPATITIS C VIRUS INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2018-04-18 EP disclosed